Close
  • All
  • Centres
  • Courses
  • Events
  • News
  • People
  • Projects
Explore more Centres, Projects and Groups
Welcome
Welcome Banner
Banner
Schista Community Worker at a participant's home with the self-sampling portable mini lab. Credit: A.Bustinduy

Schista Community Worker at a participant's home with the self-sampling portable mini lab. Credit: A.Bustinduy

Zipime Weka Schista! (Do self-testing sister!)

One-stop home self-sampling for female genital schistosomiasis, HPV, Trichomonas and HIV as a cost-effective and self-empowering strategy to increase case-detection and improve access to care for women of reproductive age in Zambia

Bottom Content
Logo List Links
Intro Blocks List
About

The Zipime Weka Schista (Schista! for short) study aims to integrate female genital schistosomiasis, a neglected tropical gynecological disease, within the wider sexual and reproductive health screening strategies.

 

Research

Integration of home self-sampling for the screening of female genital schistosomiasis with human papillomavirus (HPV) and self-testing for HIV and sexually transmitted infections is a cost-effective and self-empowering strategy that will increase the detection of cases and improve access to care for girls and women of reproductive age in sub-Saharan Africa.

Donations
Twitter Embedded Code
Facebook Embedded Code
Who we are
Who we are BILHIPV in YourSelf 2 columns
Who we are BILHIPV in YourSelf 2 columns left paragraph
Paragraph
Zipime Weka Schista! team

The Zipime Weka Schista! (Schista! for short) study brings together world-wide experts from the fields of female genital schistosomiasis, cervical cancer and HIV to propose an innovative approach to integrate multi-pathogen home-based self-sampling and testing.

Principal Investigator

Site Principal Investigator - Zambia

Study Manager

  • Rhoda Ndubani

Co-investigators

PhD students

Research
Research BILHIPV in YourSelf 2 columns
Research BILHIPV in YourSelf 2 columns left paragraph
Paragraph

This study is designed as a holistic approach to FGS detection at-scale in the community and within the wider scope of female sexual and reproductive health surveillance and linkage to care in Zambia. Female genital schistosomiasis (FGS) causes substantial morbidity in the female genital tract. Home-based genital self-sampling procedures allow discrete and convenient testing for participants with difficulty accessing a medical facility. Extending the possibility of home-based sampling for S. haematobium would allow improved diagnosis and treatment of this important condition.

This study’s emphasis on home-based testing compared with clinic-based testing will evaluate an innovative approach for future expansion of surveillance of FGS using diagnostics with high feasibility for use at scale with a special emphasis on health economics to aim for sustainability.

The Zipime Weka Schista study protocol flow. CAA circulating anodic antigen, STI sexually transmitted infection, HPV human papillomavirus
The Zipime Weka Schista study protocol flow. CAA circulating anodic antigen, STI sexually transmitted infection, HPV human papillomavirus.
Publications

Read our publications from previous studies.

Schista Publications list
Publications List
Time to bring female genital schistosomiasis out of neglect
LAMBERTI, O; BOZZANI, F; Kiyoshi, K; BUSTINDUY, AL;
2024
British Medical Bulletin
The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
Shanaube, K; Ndubani, R; KELLY, H; WEBB, E; MAYAUD, P; LAMBERTI, O; Fitzpatrick, J; Kasese, N; Sturt, A; Van Lieshout, L; Van Dam, G; Corstjens, PL A M; Kosloff, B; BOND, V; HAYES, R; TERRIS-PRESTHOLT, F; Webster, B; Vwalika, B; Hansingo, I; AYLES, H; BUSTINDUY, A;
2023
medRxiv
Chapter One - An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: The time is now
Amaya L. Bustinduy, Bodo Randriansolo, Amy S. Sturt, Seke A. Kayuni, Peter D.C. Leustcher, Bonnie L. Webster, Lisette Van Lieshout, J. Russell Stothard, Hermann Feldmeier, Margaret Gyapong
2022
Advances in Parasitology, Volume 115. doi.org/10.1016/bs.apar.2021.12.003.
Sub-studies
Sub-studies Zipime Weka Schista 2 columns
Sub-studies Zipime Weka Schista 2 columns left paragraph
Paragraph

Schista! Sub-studies

Developing a multiplex, isothermal molecular diagnostic assay for FGS and HPV

Led by Lucy Smith (PhD Candidate)

Both female genital schistosomiasis (FGS) and human papillomaviruses (HPV) cause significant gynaecological morbidity in sub-Saharan Africa. Although high-resource molecular diagnostic methods exist, women in rural areas without access to medical clinics remain neglected. To address the lack of accessible diagnostics for women in rural areas, my project’s primary aim is to develop a multiplex, isothermal molecular diagnostic assay for both FGS and HPV.

My project is funded by the MRC LID DTP in collaboration with Professor Sanjeev Krishna at St. George’s University of London, and Doctor Bonnie Webster at the Natural History Museum.

Health economics analysis to evaluate the cost-effectiveness of FGS screening strategies, as part of the Zipime-Weka-Schista study in Zambia

Led by Olimpia Lamberti (PhD Candidate)

This economic evaluation aimed to Evaluate the cost-effectiveness of home-based self-sampling and clinic-based sampling for FGS screening compared to a no screening approach (the current standard of care) using a health decision analytical model. To address this, we developed a novel health decision analytical model (the FGS-SCREEN model) to evaluate the cost-effectiveness of different FGS screening strategies. The model was then implemented as part of the Zipime-Weka-Schista study to compare the cost-effectiveness of home-based self-sampling and clinic-based sampling to a no screening approach (current standard of care). Home-based self-sampling had a lower unit cost per woman screened compared to clinic-based sampling. Neither strategy was found to be very cost-effective if implemented individually. However, a combined screening pathway incorporating home-based self-sampling in rural (80% coverage of screening-eligible population) and clinic-based screening in peri-urban areas (20% coverage of screening eligible population) was found to be very cost-effective under conservative thresholds.

Applying computer vision to female genital schistosomiasis to improve visual diagnostics

Led by Morgan Lemin (PhD Candidate)

Visual diagnosis of FGS currently involves inspecting the cervix and surrounding tissue with a colposcope to identify one of the four classic lesion types (grainy sandy patches, homogenous sandy patches, abnormal vessels and rubbery papules). This method suffers from a lack of specificity and is highly subjective. However, in lieu of a gold standard molecular test, and with evidence that older women are more commonly test positive with visual diagnostics rather than molecular, work to improve visual diagnostics is warranted.

This work aims to apply computer vision, a form of machine learning, while developing clinical support tools to enhance visual diagnostics. It is funded through the MRC LID DTP, with the support and supervision of Prof Amaya Bustinduy and Dr Chrissy H Roberts.

Male genital schistosomiasis (MGS)

Male genital schistosomiasis (MGS) typically results from the entrapment of Schistosoma haematobium eggs in the male genital tract. There are no current and accurate estimates of the burden of MGS, due to disease underreporting primarily from diagnostic challenges and a lack of general awareness within the health system. We will recruit male household members of Zipime Weka Schista study participants in order to assess the prevalence of MGS across three communities in Zambia, investigate epidemiological risk factors, and examine clinical manifestations and morbidity associated with MGS.

Updates
Updates List Block
Updates List
Training for the second Zipime Weka Schista! follow-up

The Zipime Weka Schista! study team recently gathered in Lusaka for an intensive two-day refresher training in preparation for the second follow-up phase. This hands-on workshop provided an opportunity for team members to collaborate, strategize, and refine their approach to ensure a smooth and effective follow-up process. 

The Zipime Weka Schista! team following a successful two-day retraining workshop
The Zipime Weka Schista! team following a successful two-day retraining workshop

The session was very interactive, with participants actively contributing ideas and brainstorming strategies to enhance the next phase of the study. The team’s ongoing dedication and engagement are a key reason Schista’s continued success within the community.

Our multidisciplinary team brainstorming for the next follow-up.
Our multidisciplinary team brainstorming for the next follow-up

Now fully prepped, the team is now looking forward to re-engaging with the 2532 women enrolled in the study! 

Zipime Weka Schista Study baseline results dissemination

In October 2024, members of the Schista! team travelled to Zambia to deliver the baseline results to the community and stakeholders of the Zipime Weka Schista! Study. This follows successfully recruiting 2532 women. The first follow-up has already finished, with 1766 women who have given us their confidence and were seen again by our field and clinic teams.

Schista! stakeholders in Livingstone
With the Schista! stakeholders in Livingstone after presenting and discussing the baseline results
Following a meeting with the Schista! stakeholders in Kafue after presenting the Schista! results for the area
Following a meeting with the Schista! stakeholders in Kafue after presenting the Schista! results for the area.

The Social Sciences team has also been busy conducting interviews with Schista! participants which focused on knowledge attitudes and perceptions on genital tract diseases including female genital schistosomiasis. The team has now completed 100 in-depth interviews and is in the process of transcribing them.

Schista Social Science team in Chanyanya conducting interviews
Schista Social Science team in Chanyanya conducting interviews.

It was brilliant to catch up with our in-country collaborators at Zambart and experience the ongoing engagement and enthusiasm of the local community. Work is now gearing up for the next follow-up.

Zambart and the Schista study host the first BILGENSA research Network in Lusaka Zambia

The BILGENSA (Genital Bilharzia in Southern Africa) research network had its inaugural hybrid meeting in Lusaka, Zambia on November 9th  and 10th . 14 travel grants were awarded to delegates attending from endemic countries who presented their country's ongoing work on female and male genital schistosomiasis. Research needs were highlighted per country. Thank you to the Zambart team and the Schista! Study for hosting the event! and to Marianna Kaye for helping arrange the meeting from London and Anouk Gouvras from the Global Schistosomiasis Aliance for hosting the online meeting.

Names of countries involved in the Zambart Schista study
Names of countries involved in the Zambart Schista study
Map with post its showing research country needs identified by delegates
Research country needs identified by delegates
BILGENSA delegates group picture
BILGENSA delegates group picture
Schista study team celebrate International Midwives Day

We celebrated the work of our team of midwives - Alice, Agness, Kaziku and Mercy and a blog from our wonderful midwife - sister Kaziku posted at the MARCH Centre.

Schista! study team present on International Women's Day

Our study manager Dr. Nanyangwe Siuluta and our Schista Community Worker Ruth Mwansa presented at the ISNTD panel discussion on International Women's Day integrating FGS into the Health System

Graphic showing event details for International Women's Day
The Schista study recruitment

The Schista study started recruitment on January 19th. Our teams are in the field going door to door recruiting participants and implementing self-sampling through their 'mini' portable laboratories.

Schista! team photo
Schista! study officially launched

On August 31st the Schista! study was officially launched. District Health Officers from Kafue, Chongwe and Livingstone and NTD officers from the Ministry of Health attended the virtual event.

Amaya Bustinduy, PI of the Zipime Weka Schista project awarded Future Leaders Fellowship

Amaya Bustinduy, PI of the Zipime Weka Schista project was awarded the Future Leaders Fellowship to conduct the work. Read more about the award.